⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8421142 | 1.00 | ALDH1A1 (0.36) | — | |
| SCHEMBL16924872 | 1.00 | ALDH1A1 (0.36) | — | |
| SCHEMBL577008 | 1.00 | ALDH1A1 (0.36) | — | |
| SCHEMBL2453706 | 1.00 | — | — | |
| SCHEMBL20893 | 1.00 | — | — | |
| SCHEMBL23802873 | 1.00 | ALDH1A1 (0.36) | — | |
| SCHEMBL101769 | 1.00 | — | — | |
| SCHEMBL6368791 | 1.00 | — | — | |
| SCHEMBL235448 | 1.00 | — | — | |
| SCHEMBL6742951 | 1.00 | ALDH1A1 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116396242-A | Perovskite crystal, circularly polarized luminescent material, preparation method and application thereof | 东南大学 | 2023-07-07 | — | — | CN | claimed |
| US-20250059182-A1 | SOS1 INHIBITORS | MIRATI THERAPEUTICS, INC | 2025-02-20 | — | — | US | disclosed |
| US-20230271959-A1 | HETEROCYCLIC COMPOUND AS BCL-2 INHIBITOR | BEIJING INNOCARE PHARMA TECH CO., LTD. (CN) | 2023-08-31 | — | — | US | disclosed |
| CN-116419753-A | Heterocyclic compounds as BCL-2 inhibitors | 北京诺诚健华医药科技有限公司 | 2023-07-11 | — | — | CN | disclosed |
| CN-116396242-A | Perovskite crystal, circularly polarized luminescent material, preparation method and application thereof | 东南大学 | 2023-07-07 | — | — | CN | disclosed |
| CN-116396242-A | Perovskite crystal, circularly polarized luminescent material, preparation method and application thereof | 东南大学 | 2023-07-07 | — | — | CN | disclosed |
| EP-4194454-A1 | HETEROCYCLIC COMPOUND AS BCL-2 INHIBITOR | Beijing InnoCare Pharma Tech Co., Ltd. (CN) | 2023-06-14 | — | — | EP | disclosed |
| CN-111440155-B | Chrysamide B derivative with anti-tumor activity and preparation and application thereof | 兰州大学 | 2022-08-30 | — | — | CN | disclosed |
| CN-107428891-B | Curable composition | 施敏打硬株式会社 | 2021-04-20 | — | — | CN | disclosed |
| CN-105392845-B | Photocurable composition | 思美定株式会社 | 2020-10-20 | — | — | CN | disclosed |
| US-5807858-A | DIARYLMETHYLPIPERAZINE AND PIPERIDINE COMPOUNDS; SIDE EFFECTREDUCTION OF ANALGESICS | DELTA PHARMACEUTICAL, INC. (US) | 1998-09-15 | — | — | US | disclosed |
| WO-1997046240-A1 | COMPOSITIONS AND METHODS FOR REDUCING RESPIRATORY DEPRESSION | DELTA PHARMACEUTICALS, INC. (US) | 1997-12-11 | — | — | WO | disclosed |
| US-5681830-A | DIARYLMETHYL PIPERAZINE COMPOUNDS HAVING UTILITY IN MEDICAL THERAPY AS RECEPTOR-BINDING SPECIES | DELTA PHARMACEUTICALS, INC. (US) | 1997-10-28 | — | — | US | disclosed |
| US-5658908-A | RECEPTOR BINDING SPECIES FOR MEDIATING ANALGESIA, COMBATTING DRUG ADDICTION, DRUG OVERDOSE | DELTA PHARMACEUTICALS, INC. (US) | 1997-08-19 | — | — | US | disclosed |
| US-5574159-A | DIARYLMETHYL PIPERAZINES, RECEPTOR BINDING | DELTA PHARMACEUTICALS, INC. (US) | 1996-11-12 | — | — | US | disclosed |
| US-5552404-A | COMPOUNDS FOR NEUROTRANSMITTERS FOR ANIMALS | DELTA PHARMACEUTICALS, INC. (US) | 1996-09-03 | — | — | US | disclosed |
| WO-1993015062-A1 | OPIOID DIARYLMETHYLPIPERAZINES AND PIPERIDINES | THE WELLCOME FOUNDATION LIMITED (GB) | 1993-08-05 | — | — | WO | disclosed |
| US-4885294-A | AGRICULTURE, HUMANS | PFIZER INC. (US) | 1989-12-05 | — | — | US | disclosed |
| EP-0321131-A2 | Triazole antifungal agents | Pfizer Limited (GB) | 1989-06-21 | — | — | EP | disclosed |
| US-4695383-A | COPOLYAMIDE FROM A DIAMINODIPHENYL SULFONE | TOYO BOSEKI KABUSHIKI KAISHA (JP) | 1987-09-22 | — | — | US | disclosed |